Detalles de la búsqueda
1.
Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial.
Lancet
; 399(10333): 1391-1400, 2022 04 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35381194
2.
Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy.
J Card Fail
; 29(4): 448-458, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36634811
3.
Novel multi-marker proteomics in phenotypically matched patients with ST-segment myocardial infarction: association with clinical outcomes.
J Thromb Thrombolysis
; 53(4): 841-850, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-34708315
4.
High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction.
Am Heart J
; 220: 137-144, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31812755
5.
Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imaging.
Echocardiography
; 35(11): 1746-1754, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30376596
6.
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Lancet Oncol
; 17(4): 464-474, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26968359
7.
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
Lancet Oncol
; 17(8): 1061-1069, 2016 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-27339116
8.
Frontline low-dose alemtuzumab with fludarabine and cyclophosphamide prolongs progression-free survival in high-risk CLL.
Blood
; 123(21): 3255-62, 2014 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-24735962
9.
Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.
J Thromb Thrombolysis
; 42(3): 376-85, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27324144
10.
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Lancet Oncol
; 16(3): 274-83, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25656287
11.
External Validation of the H2F-PEF Model in Diagnosing Patients With Heart Failure and Preserved Ejection Fraction.
Circulation
; 139(20): 2377-2379, 2019 05 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31082301
12.
Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.
Eur J Heart Fail
; 26(3): 628-637, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38450878
13.
Genome-wide association study (GWAS)-identified disease risk alleles do not compromise human longevity.
Proc Natl Acad Sci U S A
; 107(42): 18046-9, 2010 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-20921414
14.
The Need for Fiber Addition in Symptomatic Heart Failure (FEAST-HF): A Randomized Controlled Pilot Trial.
CJC Open
; 5(10): 760-769, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37876886
15.
Clinical Phenotypes of Heart Failure across the spectrum of Ejection Fraction: A Cluster Analysis.
Curr Probl Cardiol
; 47(11): 101337, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35878816
16.
The influence of comorbidities on achieving an N-terminal pro-b-type natriuretic peptide target: a secondary analysis of the GUIDE-IT trial.
ESC Heart Fail
; 9(1): 77-86, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34784657
17.
Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial.
Eur J Heart Fail
; 24(9): 1614-1622, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35791083
18.
Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma.
Haematologica
; 101(4): e149-52, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26659914
19.
Long-Term Clinical Outcomes Following Revascularization in High-Risk Coronary Anatomy Patients With Stable Ischemic Heart Disease.
J Am Heart Assoc
; 10(1): e018104, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33342230
20.
Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial.
Eur J Heart Fail
; 23(8): 1300-1312, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34191395